Medical Device | February 23, 2022
Medtronic receives USFDA approval for InterStim X system to manage bladder and bowel control
New InterStim X system provides 10 to 15 years of battery life without the need to recharge
New InterStim X system provides 10 to 15 years of battery life without the need to recharge
The sale is expected to close in the first quarter of 2022
The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
The brand has added a range of exciting new products especially formulated for oily skin.
With ValGenesis VLMS, change control driven validation activities are reduced from weeks to mere hours, and the company gains faster access to detailed metrics that help reduce costs and cycle time
Brian joins LEO Pharma from Novo Nordisk, U.S. where he served as Senior Vice President of Sales.
Through this acquisition, Ayu Health will add 1000 beds to provide localised primary and tertiary medical care for citizens of Jaipur
Key takeaways of recent quarter & conference call highlights
Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
Subscribe To Our Newsletter & Stay Updated
